The Coordination Gap: When Your Doctor and Pharmacist Work in Silos—and Why It Puts You at Risk

American healthcare is, in many respects, a collection of well-intentioned specialists who rarely speak to one another. A primary care physician manages chronic conditions. A cardiologist adjusts blood pressure medications. An endocrinologist oversees diabetes care. And a pharmacist—often at a retail chain, sometimes at a mail-order service the patient has never visited in person—dispenses whatever prescriptions emerge from each of those encounters. The information each provider holds about the patient is, in most cases, partial.

This fragmentation is not unique to any single practice or institution. It is a structural feature of a healthcare system built around episodic, specialty-specific encounters rather than integrated longitudinal care. And while electronic health records were intended to address some of this fragmentation, the reality is that interoperability between prescribers and pharmacies remains inconsistent, incomplete, and far less seamless than patients typically assume.

What Each Provider Doesn't Know About You

To appreciate the scope of the coordination problem, consider what information each party typically has—and lacks.

A prescribing physician generally has access to the patient's medical history within their own system, notes from previous visits, laboratory results, and imaging. What they often lack is a complete and current picture of every medication the patient is taking. Patients may be receiving prescriptions from multiple specialists. They may be purchasing over-the-counter medications, herbal supplements, or vitamins that no physician has been told about. They may have filled prescriptions at different pharmacies, none of which share data with the prescriber's electronic record.

A dispensing pharmacist, on the other hand, can see every prescription filled at that specific pharmacy location—but typically has no visibility into what a patient's physician knows about their diagnosis, recent lab values, or the clinical reasoning behind a particular prescription. When a pharmacist identifies a potential drug interaction, they may call the prescribing physician to discuss it. But in busy retail environments, these conversations are often brief, and the pharmacist may lack the clinical context needed to fully evaluate the risk.

The gap between these two knowledge bases is where patients are most vulnerable.

Real Consequences of Poor Prescriber-Pharmacist Communication

The Institute for Safe Medication Practices and other patient safety organizations have documented the kinds of errors that emerge from inadequate communication between prescribers and pharmacists. Some of the most common include:

Duplicate therapy: A patient sees two different specialists who each prescribe a medication from the same drug class without knowing the other has done so. Without a pharmacist who has visibility into both prescriptions—and who takes the time to flag the duplication—the patient may receive double the intended dose of a drug, with corresponding risks.

Missed drug interactions: A physician prescribes a new medication without full awareness of what the patient is already taking. If the pharmacist does not have a complete medication list, and if the prescriber's system does not flag the interaction, the patient receives both medications without warning.

Suboptimal dosing for renal or hepatic impairment: A pharmacist who is aware that a patient has chronic kidney disease—perhaps because it is noted in the pharmacy's records—may recognize that a newly prescribed dose is higher than recommended for that patient's level of kidney function. But if this information was not communicated to the prescriber, or if the prescriber's system does not surface it prominently, the pharmacist may be the last line of defense. And that line of defense only functions if the pharmacist has the relevant clinical information.

Missed cost-saving opportunities: A physician may prescribe a brand-name medication because it is the drug they are most familiar with, without knowing that a therapeutically equivalent generic is available at a fraction of the cost. A pharmacist who has a clinical relationship with the prescriber—and who is empowered to suggest alternatives—can often identify these opportunities. In a siloed system, they frequently do not.

Why Electronic Health Records Have Not Solved This

The widespread adoption of electronic health records was widely expected to improve care coordination, including between prescribers and pharmacists. In practice, the results have been mixed.

Most pharmacy systems are not integrated with hospital or clinic electronic health records in a way that allows real-time bidirectional data sharing. A physician can send a prescription electronically to a pharmacy, but the pharmacist's clinical notes, interaction flags, and dispensing history typically do not flow back into the prescriber's system in a structured, actionable format. The electronic prescription transmission solves the legibility problem—the era of illegible handwritten prescriptions causing dispensing errors is largely behind us—but it does not solve the information asymmetry problem.

Some health systems with integrated pharmacy services, such as those operated by large academic medical centers or integrated delivery networks, have achieved greater coordination. But for the majority of Americans who receive care from independent or small-group practices and fill prescriptions at retail pharmacies, this level of integration remains aspirational.

What Patients Can Do to Bridge the Gap

The most reliable bridge between a prescribing physician and a dispensing pharmacist is, in many cases, the patient. This places a burden on patients that should arguably be borne by the healthcare system—but acknowledging that reality does not diminish its importance. Patients who actively manage the flow of information between their providers are meaningfully safer than those who assume the system is doing it for them.

Maintain a current medication list and share it at every encounter. This list should include every prescription medication, over-the-counter drug, supplement, and vitamin—along with the dose and frequency of each. Present this list to every prescriber at every visit, and bring it to the pharmacy when filling new prescriptions.

Use a single pharmacy for all prescriptions whenever possible. A pharmacist who has a complete picture of your medication profile is far better positioned to identify interactions and flag concerns than one who sees only one of five medications you take. Many patients split prescriptions across multiple pharmacies for reasons of convenience or cost, inadvertently preventing any single pharmacist from performing a meaningful medication review.

Ask your pharmacist to conduct a comprehensive medication review. Many pharmacies offer this service, sometimes called a Medication Therapy Management (MTM) review, at no additional cost to eligible patients—particularly those with Medicare Part D coverage. During an MTM review, a pharmacist evaluates all of a patient's medications for appropriateness, safety, and adherence, and produces a written summary that can be shared with prescribers.

Explicitly ask each new prescriber whether the new medication interacts with anything you are already taking. Do not assume the prescriber has reviewed your complete medication list. Ask directly. If the prescriber is uncertain, your pharmacist can provide a more definitive answer.

Request that your pharmacist contact your prescriber when concerns arise. Pharmacists are trained to identify clinical issues and are legally and professionally empowered to communicate with prescribers. If a pharmacist raises a concern at the dispensing counter, encourage them to document it and contact the prescribing physician directly rather than simply noting it verbally to you.

Toward a More Collaborative Model

Some healthcare systems and policy advocates are pushing for a more formalized collaborative practice model, in which pharmacists and physicians operate under written agreements that define the scope of the pharmacist's clinical authority—including the ability to adjust doses, order laboratory tests, and initiate certain therapies within defined parameters. These collaborative practice agreements exist in many states and are particularly well-developed in areas such as anticoagulation management, diabetes care, and hypertension treatment.

For patients fortunate enough to receive care within such a model, the coordination gap is narrower. For the majority of Americans, however, the gap remains wide—and the most practical response is an informed, proactive patient who refuses to let critical medical information stay siloed in any single provider's office.

The physician who prescribes and the pharmacist who dispenses are both working toward the same goal: your health. The obstacle is not intent. It is information. And in the absence of a system that reliably shares that information, the patient who carries it from one encounter to the next becomes an essential part of their own safety net.